HALOZYME THERAPEUTICS INC. - US40637H1095 (Stock)
Munich
| Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
|---|---|---|---|---|---|---|
52,42 EUR
|
0,7302% | 31.07.2025 08:09 | 100,00 | 52,54 | 52,98 | 57,00 |
| Contact | |
|---|---|
|
Halozyme Therapeutics Inc. Sorrento Valley Road 92121, San Diego, CA, US |
| Phone | +1 858 794 8889 |
| Fax | +1 858 704 8311 |
| info@halozyme.com | |
| Internet | http://www.halozyme.com |
| IR Contact/PR Contact | -/- |
| Symbol | |
| End of financial year | 31.12.2025 |
| Issued capital | 6.477.935.257,30 EUR |
| Shareholders |
|---|
| Board | |
|---|---|
| Jeffrey Henderson | Chairman of Board of Directors |
| Akiko Miyashita | Member of Board of Directors |
| Barbara Duncan | Member of Board of Directors |
| Connie Matsui | Member of Board of Directors |
| Matthew Posard | Member of Board of Directors |
| Dr. Jean Bizzari | Member of Board of Directors |
| Bernadette Connaughton | Member of Board of Directors |
| Activity Description |
|---|
| - |
© 2000 - 2025 UniCredit Bank Austria AG. Please read our terms and conditions
Implemented and powered by FactSet
Fond data is provided from Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
